Women Missing Out on Opportunities From Advisory Boards
Being on an advisory board of a pharmaceutical company gives oncologists a chance to influence clinical trials and drug commercialization and to "inform decisions that affect the oncology community," say the authors of a new analysis, which found few women in such roles.Source: Medscape
Career Path: Women in Leadership at High Levels
Reaching high-level leadership positions in medicine—and specifically oncology—is not an easy task and requires significant time and dedication. For women, there are a host of additional challenges to contend with as they navigate their career.Source: Oncology Times
Disparities in Cancer Mortality Rates and Understanding Postural Orthostatic Syndrome (POTS)
Incumbent Congressman Joe Courtney (Democrat), and State Rep. Mike France (Republican), candidates in the second congressional district, faced each other in a debate hosted by Connecticut Public, and moderated by Connecticut Public’s education reporter Catherine Shen, at Eastern Connecticut State University, Tuesday.Source: Connecticut Public
Sex Differences in Gastrointestinal Cancer
With this year's Wendy U. and Thomas C. Naratil Pioneer Award and co-funding from the Yale Cancer Center, Dr. Pamela Kunz is conducting one of the first studies to examine sex differences in treating neuroendocrine neoplasms (NENs), a rare form of cancer often found in the gastrointestinal tract.
Podcast: Hidden Gems From ASCO22: Abstracts on EDI, Health Care Economics, and More
Dr. Pamela Kunz, of the Yale Cancer Center, and the JCO consultant editor for Meeting Abstracts, discusses “hidden gems” from ASCO22, highlighting abstracts that address EDI, global health, health care economics, and more.Source: ASCO Daily News
Ariadna Forray, MD and Kim Blenman, PhD, MS Take the Helm at MORE
The new co-directors of Minority Organization for Expansion and Retention (MORE), Ariadna Forray, MD, associate professor of psychiatry, and Kim Blenman, PhD, MS, assistant professor of medicine (medical oncology) and assistant professor of computer science, have been active participants in the organization and benefited from its programs and resources. They describe MORE as an essential place at Yale School of Medicine for connecting with other faculty who share their backgrounds and experiences. Now, they say, they hope to expand its reach.
JCO Consultant Editor for Meeting Abstracts Dr. Pamela Kunz Exploring Innovative Ways to Amplify Diverse Voices
Finding new ways to shine a spotlight on a broader range of abstracts featured at ASCO meetings will amplify diverse voices, advance cancer care equity, and potentially pave the way for more cancer research among minority and underserved populations in the future, according to Pamela Kunz, MD.Source: ASCO Connection
AACR Disparities Meeting: Finding Solutions to Diversify Clinical Trials
The lack of minority representation in clinical trials has adverse consequences for the health of minority patients with cancer, including limiting their access to cutting-edge therapies and preventing clinicians from understanding how generalizable a treatment’s safety and efficacy may be to non-white patients.Source: AACR Cancer Research Catalyst
Gender advocacy leads to major recognition for Yale oncologist Pamela Kunz, MD
Pamela Kunz, MD, was recently recognized as the 2021 Woman Oncologist of the Year by Women Leaders in Oncology for her commitment to advancing diversity, equity, and inclusion (DEI) through her research, committee leadership, and talks. “My advocacy is what is being recognized,” Kunz said, “To have the award acknowledge my DEI efforts is really meaningful.”
In New Role, Oncologist Aims to Build ‘Foundations of a Culture’ that Ensures Equality
Barbara Burtness, MD, understands that — in the medical profession — a culture of inclusion and diversity doesn’t just happen. It must be learned. In her new role as interim associate director for diversity, equity, and inclusion at Yale Cancer Center, she wants to help teach it.Source: Healio
Toxicity Calculators Prove Valuable Tool in Geriatric Oncology
The Cancer and Aging Research Group (CARG) calculator is a quick and helpful tool to help assess chemotherapy toxicity in geriatric patients, according to research highlighted in a press release by the Yale School of Medicine.Source: Targeted Oncology
Tackling Disparities in Oncology Requires Action as Well as Research
In this interview, Dr. Andrea Silber discusses how the COVID-19 pandemic has exacerbated disparities that already existed within oncology care, and she said the effects of these disparities on patients are very real and direct.Source: Pharmacy Times
‘We need positive destruction’: Yale doctors discuss gender equity on Clubhouse
Inginia Genao, MD, kicked off a recent Clubhouse discussion on gender equity in medicine with a sobering statistic: research shows that nearly 40% of women become part time or leave medicine within six years of completing their residency. The discussion, held May 13, was hosted by the Yale Department of Internal Medicine.
Yale Study Finds Link Between Medicaid Expansion and Equity in Cancer Care
Racial disparities in timely cancer treatment disappeared in states that expanded Medicaid under the Affordable Care Act (ACA), according to an analysis of over 30,000 health records led by researchers at Yale Cancer Center. The findings were presented at the American Society of Clinical Oncology (ASCO) 2019 annual meeting.
$1.2 million grant boosts YSPH student’s work assisting human trafficking victims
Nathan Earl ’24, a student in the Yale School of Public Health’s Executive MPH program and an anti-human trafficking advocate, was a collaborator on a recent joint $1.2 million grant awarded by the U.S. Department of Justice.